Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis
Murata, Yoko, Song, Michael, Kikuchi, Hisayuki, Hisamichi, Katsuya, Xu, Xie L., Greenspan, Andrew, Kato, Mai, Chiou, Chiun-Fang, Kato, Takeshi, Guzzo, Cynthia, Thurmond, Robin L., Ohtsuki, Mamitaro, Furue, Masutaka
Published in Journal of dermatology (01.02.2015)
Published in Journal of dermatology (01.02.2015)
Get full text
Journal Article
Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
Mease, Philip J., Gladman, Dafna D., Poddubnyy, Denis, Chakravarty, Soumya D., Shawi, May, Kollmeier, Alexa P., Xu, Xie L., Xu, Stephen, Deodhar, Atul, Baraliakos, Xenofon
Published in Rheumatology and therapy. (01.12.2023)
Published in Rheumatology and therapy. (01.12.2023)
Get full text
Journal Article
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced
Ritchlin, Christopher T, Helliwell, Philip S, Boehncke, Wolf-Henning, Soriano, Enrique R, Hsia, Elizabeth C, Kollmeier, Alexa P, Chakravarty, Soumya D, Zazzetti, Federico, Subramanian, Ramanand A, Xu, Xie L, Zuraw, Qing C, Sheng, Shihong, Jiang, Yusang, Agarwal, Prasheen, Zhou, Bei, Zhuang, Yanli, Shawi, May, Karyekar, Chetan S, Deodhar, Atul
Published in Rheumatic & musculoskeletal diseases open (01.02.2021)
Published in Rheumatic & musculoskeletal diseases open (01.02.2021)
Get full text
Journal Article
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies
Ritchlin, Christopher T, Mease, Philip J, Boehncke, Wolf-Henning, Tesser, John, Schiopu, Elena, Chakravarty, Soumya D, Kollmeier, Alexa P, Xu, Xie L, Shawi, May, Jiang, Yusang, Sheng, Shihong, Wang, Yanli, Xu, Stephen, Merola, Joseph F, McInnes, Iain B, Deodhar, Atul
Published in Rheumatic & musculoskeletal diseases open (01.03.2022)
Published in Rheumatic & musculoskeletal diseases open (01.03.2022)
Get full text
Journal Article
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study
Coates, Laura C, Gossec, Laure, Zimmermann, Miriam, Shawi, May, Rampakakis, Emmanouil, Shiff, Natalie J, Kollmeier, Alexa P, Xu, Xie L, Nash, Peter, Mease, Philip J, Helliwell, Philip S
Published in Rheumatic & musculoskeletal diseases open (26.03.2024)
Published in Rheumatic & musculoskeletal diseases open (26.03.2024)
Get full text
Journal Article
Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies
McGonagle, Dennis, McInnes, Iain B., Deodhar, Atul, Schett, Georg, Shawi, May, Chakravarty, Soumya D., Kollmeier, Alexa P., Xu, Xie L., Sheng, Shihong, Xu, Stephen, Ritchlin, Christopher T., Rahman, Proton, Mease, Phillip J.
Published in ACR open rheumatology (01.04.2023)
Published in ACR open rheumatology (01.04.2023)
Get full text
Journal Article
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo‐Controlled DISCOVER‐1 Study
Ritchlin, Christopher T., Deodhar, Atul, Boehncke, Wolf‐Henning, Soriano, Enrique R., Kollmeier, Alexa P., Xu, Xie L., Zazzetti, Federico, Shawi, May, Jiang, Yusang, Sheng, Shihong, Helliwell, Philip S.
Published in ACR open rheumatology (01.03.2023)
Published in ACR open rheumatology (01.03.2023)
Get full text
Journal Article
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis
Gottlieb, Alice B, McInnes, Iain B, Rahman, Proton, Kollmeier, Alexa P, Xu, Xie L, Jiang, Yusang, Sheng, Shihong, Shawi, May, Chakravarty, Soumya D, Lavie, Frederic, Mease, Philip J
Published in Rheumatic & musculoskeletal diseases open (01.02.2023)
Published in Rheumatic & musculoskeletal diseases open (01.02.2023)
Get full text
Journal Article
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials
Siebert, Stefan, Sweet, Kristen M, Ritchlin, Christopher T, Hsia, Elizabeth C, Kollmeier, Alexa P, Xu, Xie L, Seridi, Loqmane, Song, Qingxuan, Gao, Sheng, Chen, Warner, Miron, Michelle
Published in ACR open rheumatology (01.09.2023)
Published in ACR open rheumatology (01.09.2023)
Get full text
Journal Article
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
Mease, Philip J, Rahman, Proton, Gottlieb, Alice B, Kollmeier, Alexa P, Hsia, Elizabeth C, Xu, Xie L, Sheng, Shihong, Agarwal, Prasheen, Zhou, Bei, Zhuang, Yanli, van der Heijde, Désirée, McInnes, Iain B
Published in The Lancet (British edition) (04.04.2020)
Published in The Lancet (British edition) (04.04.2020)
Get full text
Journal Article
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Deodhar, Atul, Helliwell, Philip S, Boehncke, Wolf-Henning, Kollmeier, Alexa P, Hsia, Elizabeth C, Subramanian, Ramanand A, Xu, Xie L, Sheng, Shihong, Agarwal, Prasheen, Zhou, Bei, Zhuang, Yanli, Ritchlin, Christopher T
Published in The Lancet (British edition) (04.04.2020)
Published in The Lancet (British edition) (04.04.2020)
Get full text
Journal Article
Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III, Randomized, Double‐Blind, Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis
McInnes, Iain B., Rahman, Proton, Gottlieb, Alice B., Hsia, Elizabeth C., Kollmeier, Alexa P., Xu, Xie L., Jiang, Yusang, Sheng, Shihong, Shawi, May, Chakravarty, Soumya D., Heijde, Désirée, Mease, Philip J.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.03.2022)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.03.2022)
Get full text
Journal Article
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Deodhar, Atul, Gottlieb, Alice B, Boehncke, Wolf-Henning, Dong, Bin, Wang, Yuhua, Zhuang, Yanli, Barchuk, William, Xu, Xie L, Hsia, Elizabeth C, AELION, Jacob, AMARELO-RAMOS, Juan, BALSA, Alejandro, BERGHEA, Florian, BRZEZICKI, Jan, BURNETTE, Michael, FRETZIN, Scott, GARCÍA-CARAZO, Sara, GLADSTEIN, Geoffrey, GOMEZ-REINO, Juan, GOODERHAM, Melinda, GONZÁLEZ-FERNÁNDEZ, Carlos, GOTTLIEB, Alice, GRATACOS, Jordi, HAALAND, Derek, KAMALOVA, Rima, LESZCZYNSKI, Piotr, MARTIN-MOLA, Emilio, MASLYANSKY, Alexey, NAVARRO, Federico, OPRIS, Daniela, PAPP, Kim, PERLAMUTROV, Yuriy, PHILIPP, Sandra, RACEWICZ, Artur, REBROV, Andrey, RELL-BAKALARSKA, Maria, ROSMARIN, David, RUBBERT-ROTH, Andrea, SHERGY, William, SHIRINSKY, Ivan, SONIN, Dmitry, STANISLAV, Marina, SUKHAREV, Alexey, TEMNIKOV, Vadim, VINOGRADOVA, Irina, WAYTZ, Paul, YAKUSHEVICH, Vladimir
Published in The Lancet (British edition) (02.06.2018)
Published in The Lancet (British edition) (02.06.2018)
Get full text
Journal Article
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies
McGonagle, Dennis, McInnes, Iain B, Deodhar, Atul, Schett, Georg, Shawi, May, Kafka, Shelly, Karyekar, Chetan S, Kollmeier, Alexa P, Hsia, Elizabeth C, Xu, Xie L, Sheng, Shihong, Agarwal, Prasheen, Zhou, Bei, Ritchlin, Christopher T, Rahman, Proton, Mease, Philip J
Published in Rheumatology (Oxford, England) (03.11.2021)
Published in Rheumatology (Oxford, England) (03.11.2021)
Get full text
Journal Article
The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects
Kollmeier, Alexa, Francke, Klaus, Chen, Bin, Dunford, Paul J, Greenspan, Andrew J, Xia, Yichuan, Xu, Xie L, Zhou, Bei, Thurmond, Robin L
Published in The Journal of pharmacology and experimental therapeutics (01.07.2014)
Published in The Journal of pharmacology and experimental therapeutics (01.07.2014)
Get full text
Journal Article
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
Rahman, Proton, Ritchlin, Christopher T, Helliwell, Philip S, Boehncke, Wolf-Henning, Mease, Philip J, Gottlieb, Alice B, Kafka, Shelly, Kollmeier, Alexa P, Hsia, Elizabeth C, Xu, Xie L, Shawi, May, Sheng, Shihong, Agarwal, Prasheen, Zhou, Bei, Ramachandran, Paraneedharan, Zhuang, Yanli, McInnes, Iain B
Published in Journal of rheumatology (01.12.2021)
Published in Journal of rheumatology (01.12.2021)
Get more information
Journal Article
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis
Coates, Laura C, Ritchlin, Christopher T, Gossec, Laure, Helliwell, Philip S, Rahman, Proton, Kollmeier, Alexa P, Xu, Xie L, Shawi, May, Karyekar, Chetan S, Contré, Christine, Noël, Wim, Sheng, Shihong, Wang, Yanli, Xu, Stephen, Mease, Philip J
Published in Rheumatology (01.02.2023)
Published in Rheumatology (01.02.2023)
Get full text
Journal Article
Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis
Siebert, Stefan, Coates, Laura C., Schett, Georg, Raychaudhuri, Siba P., Chen, Warner, Gao, Sheng, Seridi, Loqmane, Chakravarty, Soumya D., Shawi, May, Lavie, Frederic, Sharaf, Mohamed, Zimmermann, Miriam, Kollmeier, Alexa P., Xu, Xie L., Rahman, Proton, Mease, Philip J., Deodhar, Atul
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.06.2024)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.06.2024)
Get full text
Journal Article
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Mease, Philip J, Helliwell, Philip S, Gladman, Dafna D, Poddubnyy, Denis, Baraliakos, Xenofon, Chakravarty, Soumya D, Kollmeier, Alexa P, Hsia, Elizabeth C, Xu, Xie L, Sheng, Shihong, Agarwal, Prasheen, Zhou, Bei, Sweet, Kristen, Shawi, May, Karyekar, Chetan S, Deodhar, Atul, van der Heijde, Désirée
Published in The Lancet. Rheumatology (01.10.2021)
Published in The Lancet. Rheumatology (01.10.2021)
Get more information
Journal Article